ANDA 63112, held by Hospira. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 63112 (Tobramycin Sulfate), held by Hospira, was first approved by FDA on Apr 30, 1991, with 12 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 30, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tobramycin SulfateEQ 10MG BASE/ML · injectable;injection | Tobramycin Sulfate | Discontinued |
| Feb 10, 2023 | Supplement 22Labeling · Standard review | Approved | None posted |
| Sep 18, 2015 | Supplement 19Labeling · Standard review | Approved | None posted |
| Jan 12, 2012 | Supplement 15Labeling | Approved | |
| Apr 7, 2005 | Supplement 10Labeling | Approved | None posted |
| Apr 7, 2005 | Supplement 11Labeling | Approved | None posted |
| Apr 27, 2004 | Supplement 9Labeling | Approved | None posted |
| Oct 25, 2002 | Supplement 8Manufacturing | Approved | None posted |
| Feb 16, 1999 | Supplement 7Manufacturing | Approved | None posted |
| Oct 3, 1996 | Supplement 5Manufacturing | Approved | None posted |
| Dec 10, 1993 | Supplement 3Labeling | Approved | None posted |
| Apr 2, 1993 | Supplement 2Manufacturing | Approved | None posted |
| Nov 15, 1991 | Supplement 1Labeling | Approved | None posted |
| Apr 30, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters